For the quarter ending 2026-03-31, CNMD made $317,046K in revenue. $13,828K in net income. Net profit margin of 4.36%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Net sales | 317,046 | 370,368* | 337,926 | |
| Cost of sales | 133,599 | 108,828* | 171,807 | |
| Gross profit | 183,447 | 261,540* | 166,119 | |
| Selling and administrative expense | 141,699 | 170,952* | 140,339 | |
| Research and development expense | 16,333 | 14,181* | 13,901 | |
| Operating expenses | 158,032 | 185,133* | 154,240 | |
| Income from operations | 25,415 | 76,407* | 11,879 | |
| Other expense | 0 | 418* | 0 | |
| Interest expense | 7,060 | 8,269* | 7,606 | |
| Income before income taxes | 18,355 | 67,720* | 4,273 | |
| Provision for income taxes | 4,527 | 19,820* | 1,414 | |
| Net income | 13,828 | 47,900* | 2,859 | |
| Cash flow hedging | - | -1,716* | - | |
| Pension liability | - | -856* | - | |
| Foreign currency translation adjustments | - | 3,794* | - | |
| Other comprehensive income (loss), before income tax | - | 2,933* | - | |
| Provision (benefit) for income taxes related to items in other comprehensive income (loss) | - | -208* | - | |
| Other comprehensive income (loss), net of income tax | - | 3,141* | - | |
| Comprehensive income | - | 51,040 | - | |
| Basic EPS | 0.45 | 1.64 | 0.09 | |
| Diluted EPS | 0.45 | 1.633 | 0.09 | |
| Basic Average Shares | 30,588,000 | 31,117,000 | 30,955,000 | |
| Diluted Average Shares | 30,621,000 | 31,248,000 | 31,050,000 | |
CONMED Corp (CNMD)
CONMED Corp (CNMD)